Literature DB >> 18819236

Aortic stenosis: diagnosis and treatment.

Brian H Grimard1, Jan M Larson.   

Abstract

Aortic stenosis is the most important cardiac valve disease in developed countries, affecting 3 percent of persons older than 65 years. Although the survival rate in asymptomatic patients with aortic stenosis is comparable to that in age- and sex-matched control patients, the average overall survival rate in symptomatic persons without aortic valve replacement is two to three years. During the asymptomatic latent period, left ventricular hypertrophy and atrial augmentation of preload compensate for the increase in afterload caused by aortic stenosis. As the disease worsens, these compensatory mechanisms become inadequate, leading to symptoms of heart failure, angina, or syncope. Aortic valve replacement should be recommended in most patients with any of these symptoms accompanied by evidence of significant aortic stenosis on echocardiography. Watchful waiting is recommended for most asymptomatic patients, including those with hemodynamically significant aortic stenosis. Patients should be educated about symptoms and the importance of promptly reporting them to their physicians. Serial Doppler echocardiography is recommended annually for severe aortic stenosis, every one or two years for moderate disease, and every three to five years for mild disease. Cardiology referral is recommended for all patients with symptomatic aortic stenosis, those with severe aortic stenosis without apparent symptoms, and those with left ventricular dysfunction. Many patients with asymptomatic aortic stenosis have concurrent cardiac conditions, such as hypertension, atrial fibrillation, and coronary artery disease, which should also be carefully managed.

Entities:  

Mesh:

Year:  2008        PMID: 18819236

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  11 in total

1.  Renal Transplantation after Transcatheter Aortic Valve Replacement: Case Report.

Authors:  Keerthana Gangadharan; Reshmibhat Parameswaranunni; Massini Merzkani; Ernesto Molmenti; Madhu Bhaskaran
Journal:  Int J Angiol       Date:  2018-09-14

2.  Efficient detection of aortic stenosis using morphological characteristics of cardiomechanical signals and heart rate variability parameters.

Authors:  Arash Shokouhmand; Nicole D Aranoff; Elissa Driggin; Philip Green; Negar Tavassolian
Journal:  Sci Rep       Date:  2021-12-10       Impact factor: 4.379

3.  Omentin-1: One Novel Biomarker for Calcified Aortic Valve Stenosis.

Authors:  Zong-Yun Tsai; Ping-Yen Liu
Journal:  Acta Cardiol Sin       Date:  2022-09       Impact factor: 1.800

Review 4.  Asymptomatic Severe Aortic Stenosis: Contemporary Evaluation and Management.

Authors:  Mohamed Salah Abdelghani; Sundus Sardar; Abdelhaleem Shawky Hamada
Journal:  Heart Views       Date:  2022-05-16

5.  Improvement of aortic valve stenosis by ApoA-I mimetic therapy is associated with decreased aortic root and valve remodelling in mice.

Authors:  J Trapeaux; D Busseuil; Y Shi; S Nobari; D Shustik; M Mecteau; I El-Hamamsy; M Lebel; R Mongrain; E Rhéaume; J-C Tardif
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

6.  Perioperative nitroprusside infusion in a patient with severe aortic stenosis: another component of afterload reduction uncovered.

Authors:  Ashish K Khanna; Kamal Maheshwari; Wael Ali Sakr Esa
Journal:  Ochsner J       Date:  2013

7.  VEGF attenuates development from cardiac hypertrophy to heart failure after aortic stenosis through mitochondrial mediated apoptosis and cardiomyocyte proliferation.

Authors:  Xiao H Xu; Jing Xu; Lei Xue; Hai L Cao; Xiang Liu; Yi J Chen
Journal:  J Cardiothorac Surg       Date:  2011-04-16       Impact factor: 1.637

8.  Aortic Valve Replacement for Aortic Stenosis and Concomitant Coronary Artery Bypass: Long-term Outcomes and Predictors of Mortality.

Authors:  Won-Chul Cho; Dong-Gon Yoo; Joon-Bum Kim; Jae-Won Lee; Suk-Jung Choo; Sung-Ho Jung; Cheol-Hyun Chung
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-04-14

9.  Pathologic Shear and Elongation Rates Do Not Cause Cleavage of Von Willebrand Factor by ADAMTS13 in a Purified System.

Authors:  Maria Bortot; Alireza Sharifi; Katrina Ashworth; Faye Walker; Allaura Cox; Katherine Ruegg; Nathan Clendenen; Keith B Neeves; David Bark; Jorge Di Paola
Journal:  Cell Mol Bioeng       Date:  2020-07-17       Impact factor: 2.321

10.  C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload.

Authors:  Xiaomin Wang; Wei Li; Qiang Yue; Wei Du; Yongming Li; Fu Liu; Liu Yang; Lijuan Xu; Ruiping Zhao; Jiang Hu
Journal:  Mol Med Rep       Date:  2020-11-17       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.